This Week in HIV Research: New PrEP Drug Prevents HIV in Animal Models, and Prime-Boost HIV Vaccine Study Shows PromiseBy Barbara Jungwirth
New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) says the Pre-Exposure Prophylaxis (PrEP) ring, also known as the dapivirine ring, can reduce HIV infection in women by 50 percent. PrEP is a drug people at risk of HIV take to prevent contracting the virus from sex or injection dr...
(PrEP) amongst women at high risk of HIV acquisition, this study explored the attitudes and preferences of female sex workers (FSW) ( n = 15) and women who inject drugs (WWID) ( n = 16) to existing (e.g., pill) and new (e.g., injection, implant) PrEP modalities, ...
Preliminary data suggest that new HIV diagnoses at STI clinics have fallen across England. This may partly be due to people buying preventative drugs online
After major advances in HIV treatment over the last 25 years, new drugs and experimental treatments in the pipeline may bring more improvements to care.
hiv pre-exposure prophylaxis (prep)-knowledge and attitudes among a new york city emergency department patient population Y Calderon,J Leider,E Cowan,... 被引量: 0发表: 2017年 Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. ObjectivesTo ...
Society–USA panel.9These new recommendations bolster what we already knew: the evidence in support of expanded HIV screening and PrEP is strong. However, the guidelines do not address some of the hard lessons we are learning: screening and PrEP are merely points of entry to a pathway of ...
本月在美国HIV/AIDS会议上发表的一项在乌干达和肯尼亚进行的研究表明,如果有选择的话,有HIV风险的人会选择CAB-LA而不是口服PrEP——但仅仅有选择就增加了PrEP的总体使用。“人们对注射PrEP很感兴趣,”马凯雷雷大学(Makerere University)的流行病学家Moses Kamya说,这“不仅仅是取代口服PrEP”。“它扩大了蛋糕。” ...
For many young MSM, the time-period of highest HIV risk occurs during their college years. While college student health services (SHS) are uniquely positioned to provide HIV prevention services, little is known about the availability of PrEP in those settings. A new survey of medical directors ...
PrEP, a pill taken once a day, reduces the risk of HIV infection via sex or injection drug use by up to 99 percent. Since 2012, there has been one FDA-approved PrEP formulation: the combination of tenofovir/emtricitabine (F/TDF), marketed by Gilead Sciences and sold under the brand name...